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Preventing HAPUs in High-Risk Cardiac Cath Patients
Using Foam Dressing Protocol
Clinical Leadership Theme
My Clinical Nurse Leader (CNL) improvement project is entitled Preventing HAPUs in
High-Risk Cardiac Cath Patients Using Foam Dressing Protocol. Its clinical leadership theme
is patient safety, which is one of the six quality dimensions recommended by the Institute of
Medicine “when working to improve health care” (Nelson, Batalden, & Godfrey, 2007). A CNL
is a master’s prepared registered nurse “with a focus on quality improvement and care
coordination” (Harris, Roussel, Thomas, 2014). My global aim statement is to improve patient
safety by preventing hospital-acquired pressure ulcers (HAPUs) in the cardiac catheterization lab
(CCL). The process begins at the point of care on admission and ends after a final skin
assessment is performed and the patient is discharged. I expect 0% HAPUs for patients
receiving care in the CCL.
I chose the following required clinical experience “Work with quality improvement team
and engage in designing and implementing a process for improving patient safety” as the
framework for my project (AACN, 2015). This Systems Analyst/Risk Anticipator competency
aligns with the clinical leadership theme as the CNL functioning in this role “Participates in
system reviews Evaluates/anticipates client risks to improve patient safety” (2015). Additional
relevant framework competencies include analyzing the microsystem and applying evidencebased practice.
Statement of the Problem
While collecting microsystem data in previous CNL role courses I discovered a
performance gap that inspired my N653 CNL Internship project. In spite of having already
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decreased the total number of HAPUs by 50% in 2015, the CCL was implicated in 30% of those
reported. Lengthy procedures such as transcatheter aortic valve replacement (TAVR),
MitraClip®, Watchman™, and biventricular pacemakers are performed each week in the CCL
and can last several hours or more. Once positioned, patients are immobilized and remain supine
for the duration of the procedure as we are not able to turn or reposition patients intraoperatively,
subjecting their sacrum and other bony prominences to constant friction and pressure.
A review of literature established that “All surgical patients should be considered to be at
risk for pressure injuries, including pressure ulcers” (Cherry & Moss, 2011). Aside from
pre/post procedural skin assessments we offer no prophylactic or preventative intervention for
these individuals who are at high risk for developing HAPUs. A change in practice is essential
as Ghavidel, Bashavard, Bakhshandeh Abkenar, and Mehdi Payghambari (2012) report HAPU
rates post cardiac surgery as high as 21%.
Project Overview
In my microsystem we are committed to safety through continuous improvement
initiatives. Protecting our members from harm “requires everyone to be involved in identifying
opportunities where patient care can be made safer” (AHA, 2016). In order to achieve and
maintain optimal patient outcomes, “safety must be a property of the system” (IHI, 2016).
Ultimately my goal is to accomplish safer cardiac catheterization procedures as evidenced by the
absence of HAPUs. This project is extremely important because HAPUs are costly (no CMS
reimbursement for treatment and/or increased length of stay) and there are also legal and
regulatory implications. Additionally, “HAPUs are responsible for significant patient harm in
the form of pain, increased susceptibility to infection, and delayed recovery” (2011).
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My specific aim is to improve patient safety by reducing the number of HAPUs acquired
in the CCL to 0% by three months using a prophylactic foam dressing protocol. It was derived
from my global aim statement and is the result of failure modes and effects analysis (FMEA),
process and cause and effect analyses, and evidence-based/best practices (2007). The
measurable outcome represents the CCL percentage of total facility HAPUs based on final skin
assessment prior to discharge.
Rationale
Prior to selecting my project I performed a comprehensive needs assessment in order to
gain a better understanding of my microsystem’s current state and to locate gaps in performance.
While performing my 5 P’s assessment my preceptor assisted me in obtaining Regional Risk
Management SB 1301 (Department of Public Health) reports which present monthly HAPU
incidence at the macrosystem levels. Further inquiry revealed that the CCL was implicated in
30% of 2015 HAPUs including two TAVR patients. This information was subsequently shared
with the vascular and CCL staff caring for these patients.
The costs associated with this project are small when compared to its potential savings
and benefits (see Budget Table in Appendix E). The amount of money this project will save is
significant as CMS discontinued reimbursement for HAPUs in 2008 in addition to intangible
costs such as pain and suffering and organization reputation. The net benefit (savings) of this
project using the lower estimate for treatment plus fines for the 30% of HAPUs reported in 2015
is $187,142.60.
Methodology
The objective and specific evidence-based changes in practice involve prospective data
collection, enhanced skin assessments, and the application of foam dressings in patients deemed
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high-risk for developing sacral HAPUs and/or those whose procedures are anticipated to last
three hours or more. I will personally collect all project data however the latter two changes are
the responsibility of the microsystem and its professionals. Patient selection will be
predetermined based on daily catheterization schedule. I created an excel spreadsheet to audit
compliance and track the outcome measure (absence of reportable HAPUs) using my
organization’s electronic health record, HealthConnect®.
I chose Lewin’s change theory for developing my CNL project based on the needs of the
project itself and the unique characteristics of my microsystem’s professionals, which consists of
leaders and effective team members. The discovery of a performance gap necessitated a need for
change, or unfreezing. Movement represents PDSA cycles where small tests of change, in this
case the application of sacral dressings in high-risk patients for HAPU prevention along with
subsequent skin assessment tracking, are executed and evaluated. The most significant driving
force for my project based on SWOT analysis is microsystem support. Champions emerged as
expected and immediately began implementing foam-dressing protocol. Lastly, refreezing is
when the evidence-based change in practice will become the standard of care.
As team leader and change agent my first PDSA-Do action will be innovation diffusion
and selecting/partnering with early adopters. Other actions include providing transformational
leadership and collecting, analyzing, and comparing data in order to determine program
effectiveness. Patient demographics along with procedure type will be gathered from the
catheterization schedule. The patient’s EHR will be used for studying pre/post skin assessments
for the outcome measure (presence/absence of HAPU). Based on SWOT analysis I predict
successful implementation as well as 0% HAPUs for patients receiving care in the CCL by one
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month. Outcome measure predictions will be ongoing and compared monthly with expected
results using Regional Risk Management SB 1301 reports.
Data Source/Literature Review
The focus of my study involves Regional Risk Management SB 1301 reports. These
reports, accessible only through my preceptor, show monthly HAPU incidence at both the
regional and facility levels. This report is particularly appropriate as the CCL was implicated in
30% of those reported in 2015. Also, HAPU reporting is mandatory—failure to do so may incur
fines up to $25,000.00 per incident.
I began my literature review by formulating the following PICO statements (C represents
no treatment): In cardiac catheterization patients does using a sacral foam dressing reduce the
risk HAPUs? In high risk patients does Mepilex® Border Sacrum reduce HAPU incidence? I
utilized the CINAHL Complete database via Gleeson Library to locate relevant sources however
statement and combination searches retrieved few results. Determined, I was able to locate a
multitude of information by searching for PICO items individually. I found websites such as
Agency for Healthcare Research and Quality, American Hospital Association, Institute for
Healthcare Improvement, and Institute of Medicine to be extremely useful as well.
The literature included in the literature review supports my project’s specific aim and
evidence-based change in practice: to improve patient safety by reducing the number of HAPUs
acquired in the CCL to 0% by three months using a prophylactic foam dressing protocol. It also
supports the improvement theme, global aim, business case, methodology, change theory,
implementation, and barriers. See annotated bibliography for materials used for research
evidence including current, peer-reviewed journal articles as well as Mepilex® Border Sacrum
product information.
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Timeline
Pilot testing is already in progress as project questionnaire has been distributed and
dressings are available in each lab. Formal project implementation and data collection will begin
in April 2016. It was decided that dressing application is the responsibility of all microsystem
professionals. I will be closely observing PDSA-Do phase as well as collecting, analyzing, and
comparing all data. Please see timeline in Appendix F for more detail as well as dates each step
is due to be completed.
Expected Results
As stated in the Clinical Leadership Theme section, I expect 0% HAPUs for patients
receiving care in the CCL when I compare my data with Regional Risk Management SB 1301
reports in February 2017. I base this expectation on overwhelming support for this project
including physicians, leadership, and all microsystem professionals consisting of leaders and
effective followers who are more than willing to make patient safety their priority. Each one
understands that this is not a just a school project but an evidence-based change in practice that
will provide safer procedures resulting in zero HAPUs.
Nursing Relevance
My facility’s WOCN certified Surgical CNS implemented a similar improvement project
in perioperative services after a percentage of patients undergoing cardiovascular surgery
developed HAPUs. To our knowledge my project is unique in that HAPU prevention has not
been studied extensively in CCL patients and warrants further research and publication. My
project has nursing relevance and contributes to our present understanding of HAPU prevention
in an understudied microsystem/patient population. Also, improving patient outcomes is
important for nurses. The American Nurses Association Code of Ethics for Nurses With
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Interpretive Statements states, “Nurses must participate in the development, implementation, and
review of and adherence to policies that promote patient health and safety, reduce errors and
waste, and establish and sustain a culture of safety” (ANA, 2016).
Summary Report
As stated previously, the objective of my CNL Internship project was to improve patient
safety by reducing the number of HAPUs acquired in the CCL to 0% by three months using a
prophylactic foam dressing protocol. The actual population encompassed all patients undergoing
lengthy (estimated three hours or more), complex cardiac catheterization procedures with or
without anesthesia including chronic total occlusions (CTOs), TAVR, MitraClip®, Watchman™,
biventricular implanted devices, and/or any patient who might benefit from sacral protection
based on nursing assessment and/or provider discretion. The setting included three cardiac
catheterization labs and one hybrid suite.
Methods used to implement project were unchanged from prospectus. They involved
prospective data collection, enhanced skin assessments, and the application of foam dressings in
patients deemed high-risk for developing sacral HAPUs and/or those whose procedures are
anticipated to last three hours or more. Baseline data gathered from needs assessment revealed
that the CCL was implicated in 30% of 2015 HAPUs including two TAVR patients. A posttest
was administered to all CCL staff following instruction (see Appendix G).
To date 80 patients met procedural inclusion criteria. All were administered prophylactic
sacral dressings and subsequently tracked for the outcome measure using EHRs. As predicted,
zero patients treated with prophylactic sacral dressing experienced HAPUs based on discharge
skin assessments. Post implementation data demonstrated a reduction in the number of HAPUs
acquired in the CCL from 30% to 0% at eight weeks. This project is sustainable as dressings are
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readily available in each lab and implementation is successfully being incorporated into
workflow. I conclude that this evidence-based change in practice effectively reduces HAPUs in
high-risk CCL patients.
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Appendix A
Preventing HAPUs in High-Risk Cardiac Cath Patients Using Foam Dressing Protocol
Fishbone Diagram
Patient
Positioning

Patient
Factors

No prophylactic or
preventative measures

Advanced age
Comorbidities

Immobilization
Hemodynamic instability
Difficult and potentially
unsafe at times

Nutrition status

Large patients may put staff
at risk for injury

HAPU
Formation

Procedures lasting 3
hours or more
Case length highly variable
based on procedure type

Cycle
Times
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Preventing HAPUs in High-Risk Cardiac Cath Patients Using Foam Dressing Protocol
Flowchart
Start






Final Q&A session/charge meeting
Designate champions
Develop audit tool
Begin pilot test




Implement PDSA-Do phase
Discuss experiences with teams
Create Excel tool for data collection



Collect compliance data and discharge
skin assessments for outcome measure
Provide feedback









Continue PDSA-Do phase
Study the data and make changes as
necessary

No
Standardize project?

Yes



Make
changes as
necessary



Compare project data with Regional
Risk Management SB 1301 reports
February 2017
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Appendix C

Preventing HAPUs in High-Risk Cardiac Cath Patients Using Foam Dressing Protocol
SWOT Analysis
Strengths (Internal)


Overwhelming support from

Weaknesses (Internal)


Positioning of patient for dressing

physicians, leadership, and all

placement/removal in certain situations

microsystem professionals

(unsafe during mechanical ventilation,



Direct purchasing of supplies

intra aortic balloon counterpulsation,



Fully integrated EHR for tracking

etc. Also, positioning large patients

project data

may put staff at risk for injury)



Dressings are relatively inexpensive,
already approved for purchase, and
easy to apply/remove
Opportunities (External)





Partner with Vascular and

Threats (External)


Initial skin/risk assessments and

Interventional Radiology departments

dressing application/removal will at

Opportunity for enhanced assessment,

times be provided by adjacent

collaboration, and teambuilding

microsystems (threat to data collection)


Hybrid catheterization lab poses a
potential threat, as it is located two
floors above the rest of the
microsystem
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Appendix D
Preventing HAPUs in High-Risk Cardiac Cath Patients Using Foam Dressing Protocol
Stakeholder Analysis





Organization
(regulatory)
Physicians
Leadership





Preceptor
Champions
Early Adopters

Unlicensed
Professionals
Laggards




Patients
Late
Majority

Influence




Interest
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Appendix E
Preventing HAPUs in High-Risk Cardiac Cath Patients Using Foam Dressing Protocol
Budget Table
Personnel
Personnel (0.6 FTE):

Cost:
$15,855

Non-personnel
Start-up medical supplies:

$1,542

Total Start-Up Operating Expenses

$17,397

CNL Improvement Project Net Benefit (Savings)

$187,142
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Appendix F
Preventing HAPUs in High-Risk Cardiac Cath Patients Using Foam Dressing Protocol
Gantt Chart 2016-2017
2015

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar

Task 1
Task 2
Task 3
Task 4
Task 5
Task 6
Definitions:
Task 1: Final Q&A session/charge meeting; designate champions; develop audit tool; begin pilot test.
Task 2: Implement PDSA-Do phase; discuss experiences with teams; create Excel tool for data collection.
Task 3: Collect compliance data and discharge skin assessments for outcome measure; provide feedback.
Task 4: Continue PDSA-Do phase; study the data and make changes as necessary.
Task 5: Standardize project.
Task 6: Compare project data with Regional Risk Management SB 1301 reports February 2017.
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Appendix G
Preventing HAPUs in High-Risk Cardiac Cath Patients Using Foam Dressing
Protocol Posttest
1. True or False CCL patients are high-risk for HAPU based on advanced age,
comorbidities, and hemodynamic instability.
2. True or False Foam dressing protocol is appropriate for all CCL patients.
3. True or False Senate Bill 1301 requires optional reporting of all HAPUs along
with an administrative penalty not to exceed $25,000.
4. True or False The Centers for Medicare & Medicaid, The Joint Commission,
Agency for Healthcare Research Quality, National Quality Forum, and Institute
for Healthcare Improvement all recognize pressure ulcers as a quality indicator.
5. True or False Preventing HAPUs enhances the quality of services we provide
our members.
6. True or False HAPUs are costly (no CMS reimbursement for treatment and/or
increased length of stay) and there are also legal and regulatory implications.
7. True or False The CCL was implicated in 30% of 2015 HAPUs including two
TAVR patients.
8. True or False Dressing application is the responsibility of all microsystem
professionals.
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